Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06436157 · ClinicalTrials.gov registry record · NA

A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention

A NA study of Solid Tumor, Adult, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
2
Study locations

NCT06436157: Recruiting NA study of Solid Tumor, Adult, sponsored by University of California, Davis.

NCT06436157 is a NA study of Solid Tumor, Adult that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 60 participants, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (68% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06436157, a NA study of Solid Tumor, Adult, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
2
Study locations

Study Summary

Genetic factors are a significant determinant of the likelihood of developing various types of cancers. Identification of germline risk can have important implications for both patients and their families. Although estimates vary, pathogenic germline variants can be seen in \~3-17.5% of unselected patients with cancer with important clinical significance. Unfortunately, despite progress in multigene testing and the identification of heritable conditions, genetic counseling and testing (GCT) remains underutilized among cancer patients. Although there are multiple barriers to low testing, initial referral to GCT from the treating oncologist has been noted to be the most significant barrier. Nurse navigation has been shown to improve the timeliness of cancer care and patient outcomes across various cancer types and improve the uptake of genomic testing in cancer patients. Despite proven benefits, community cancer centers often face resource limitations that prevent them from consistently assigning a dedicated nurse navigator to cancer patients. However, community centers universally have oncology nurses who routinely educate patients about their systemic therapies. By enhancing the "therapy education" sessions, the investigators hypothesize that oncology nurses can bridge this gap and potentially identify eligible patients, provide essential education on the importance of genetic testing, and facilitate the referral process. The investigators propose a pilot randomized study to evaluate the potential effectiveness, acceptability, and feasibility of a novel, nurse-led "enhanced education" intervention specifically designed to increase the uptake of GCT in adult cancer patients.

Conditions Studied

Interventions

  • OTHER Enhanced education
  • OTHER Usual care education

Study Locations (2)

California

  • Enloe Regional Cancer Center - Chico
  • University of California, Davis - Sacramento

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-12-26
Est. Completion 2025-09-26
Phase NA
University of California, Davis

657 total trials

What NCT06436157 shows while recruiting

NCT06436157 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 190-participant average among 72 other Solid Tumor, Adult trials with a reported enrollment target (68% lower).

The record links to 1 condition, with Solid Tumor, Adult appearing as the primary indexed condition, and to 2 interventions - of which Enhanced education is the first listed.

NCT06436157 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06436157 about?

NCT06436157 is a clinical study titled "A Pilot Study of Genetic Testing Uptake Through Enhanced Oncology Nurse-Led Intervention". Genetic factors are a significant determinant of the likelihood of developing various types of cancers. Identification of germline risk can have important implications for both patients and their families. Although estimates vary, pathogenic germline variants can be seen in \~3-17.5% of unselected p...

What is the current status of trial NCT06436157?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-12-26. Estimated completion is 2025-09-26.

What conditions does trial NCT06436157 study?

This clinical trial studies the following conditions: Solid Tumor, Adult.

What interventions are being tested in trial NCT06436157?

The interventions under investigation include: Enhanced education (OTHER), Usual care education (OTHER).

Who is sponsoring clinical trial NCT06436157?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06436157 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Solid Tumor, Adult

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06436157's enrollment target sits among peer trials

60 52nd of 72 higher than 19 of 72 other Solid Tumor, Adult trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Solid Tumor, Adult trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06436157, the US trial registry maintained by the National Library of Medicine. NCT06436157 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.